Curdlan sulfate vitro inhibitory effects curdlan sulfate infection Action mechanisms polysaccharide curdlan sulfate CRDS human immunodeficiency virus type infection vitro syncytium formation microassay antigen capture enzyme-linked immunosorbent assay assays titer infectious virions amounts core antigen soluble intraviral intracellular forms CRDS treatments degrees cells micrograms/ml CRDS infection CRDS-treated virions able cells untreated virions simultaneous treatment cells virions CRDS significant inhibition infection temporary disappearance virions dose CRDS contrast CRDS treatment cells significant decrease titer infectious amounts forms absolute elimination results CRDS binding envelope cell surface emphasis high affinity CRDS envelope 